FDA Inspection 1010068 — Fresenius Kabi Oncology Limited
The FDA completed an inspection of Fresenius Kabi Oncology Limited on Apr 14, 2017 in Baddi. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Apr 14, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Baddi (India)